Asynchronous Movies for Amblyopia

Sponsor
Retina Foundation of the Southwest (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05439200
Collaborator
(none)
44
2
56

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether viewing asynchronous movies leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to treatment.

Condition or Disease Intervention/Treatment Phase
  • Device: Asynchronous 3D movies
  • Device: Patching
N/A

Detailed Description

This is a single-site randomized clinical trial to compare treatment of amblyopia by viewing asynchronous movies to standard-of-care occlusion therapy with an adhesive patch. Participants will be referred from local pediatric ophthalmologists. Following informed consent, children will complete baseline testing to confirm eligibility and provide pre-treatment measurements of visual acuity, suppression, stereoacuity, motor skills, self-perception, and quality of life. Eligible children will then be randomly allocated to either patch-free occlusion therapy or standard-of-care occlusion therapy with an adhesive patch.

Children will participate in their assigned occlusion therapy at home for 6 weeks (primary outcome). Adherence will be objectively monitored. Vision will be re-assessed at 2 and 4 weeks and all tests will be repeated at 6 weeks. The asynchronous movie group will have an option to continue for and additional 2 or 4 weeks (10 weeks total). The standard-of-care occlusion group will be offered the opportunity to use the movie treatment at the 6 week visit through 10 weeks. Children who choose to remain in the study beyond the 6 week primary outcome visit will have vision reassessed at 8 and 10 weeks.

The primary analysis will be a comparison of improvement in amblyopic eye visual acuity (baseline-6 weeks) between the movie group and the standard-of-care patching group. Secondary analyses will include comparisons of adherence to each treatment, comparison of the proportion of children in each group with visual acuity ≤0.1 logMAR (recovered) at 6 weeks and 95% CIs, comparisons of changes in extent of suppression, depth of suppression, stereoacuity, motor skills standard scores, self-perception scores, and PedEyeQ domain scores. Associations among hours of treatment, changes in visual acuity, suppression, and stereoacuity, will be explored and modeled for dose-response relationships. In exploratory analyses, we will examine whether there are additional improvements in visual acuity, suppression, or stereoacuity between 6 and 10 weeks for the movie group (8 and 10 weeks means and 95% CIs).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Asynchronous Movies for Amblyopia
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2027
Anticipated Study Completion Date :
Dec 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Asynchronous movies

Asynchronous 3D movies

Device: Asynchronous 3D movies
3D movies streamed at home for viewing on a handheld lenticular 3D screen

Active Comparator: Standard-of-care patching with an adhesive patch

Standard-of-care patching with an adhesive patch

Device: Patching
Adhesive patch to cover the fellow eye

Outcome Measures

Primary Outcome Measures

  1. Change in amblyopic eye visual acuity using a logMAR chart [6 weeks]

    change in amblyopic eye logMAR visual acuity relative to baseline

Secondary Outcome Measures

  1. Change in amblyopic eye visual acuity using a logMAR chart [2, 4, 8, and 10 weeks]

    change in amblyopic eye logMAR visual acuity relative to baseline at 2, 4, 8, and 10 weeks

  2. Change in extent suppression assessed with the W4 test [6 weeks]

    change in log deg assessed with the W4 test relative to baseline

  3. Change in stereoacuity assessed with the Randot Preschool Stereoacuity Test [6 weeks]

    change in log arcsec in stereoacuity assessed with the Randot Preschool Stereoacuity Test

  4. Change in motor skills assessed with the Movement Assessment Battery for Children -2 [6 weeks]

    change in standard scores obtained with the Movement Assessment Battery for Children -2 (MABC-2; (normed and scaled 0-19, with 10 as an average score, 5-6 as "at risk", and <5 as "significant impairment")

  5. Change in self perception assessed with the Pictorial Scale of Perceived Competence and Social Acceptance for Young Children [6 weeks]

    change in domain scores of the Pictorial Scale of Perceived Competence and Social Acceptance for Young Children (standard scores scaled to range from 0 to 100 for worst to best)

  6. Change in quality of life assessed with the Pediatric Eye Questionnaire [6 weeks]

    change in domain scores of the Pediatric Eye Questionnaire (PedEyeQ; Rasch calibrated and scaled to score from 0 to 100 for worst to best)

  7. Proportion of children who have recovered [2, 4, 6, 8, and 10 weeks]

    proportion of children who attain amblyopic eye visual acuity of at least 0.1 logMAR

  8. Adherence to patching measured with a sensor and adherence to viewing videos measured with the streaming log data [2,4, and 6 weeks]

    cumulative hours of treatment with the patch objectively monitored temperature sensitive Theramon sensor or with movie viewing by monitoring the streaming logs

  9. Change in depth of suppression assessed with the contrast balance index [6 weeks]

    change in contrast balance index (ratio of amblyopic eye to fellow eye contrast needed to overcome suppression

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 7 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 3-7 years

  • male and female

  • strabismic, anisometropic, or combined mechanism amblyopia (visual acuity 0.3-0.8 logMAR)

  • interocular visual acuity difference ≥0.3 logMAR

  • wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart

  • child's ophthalmologist and family willing to forgo standard patching treatment during the study

Exclusion Criteria:
  • prematurity ≥8 wk

  • coexisting ocular or systemic disease

  • developmental delay

  • strabismus >5 pd

  • myopia > -3.00D

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Retina Foundation of the Southwest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eileen Birch, Senior Research Scientist, Retina Foundation of the Southwest
ClinicalTrials.gov Identifier:
NCT05439200
Other Study ID Numbers:
  • RFSW113B
First Posted:
Jun 30, 2022
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022